END OF LIFE PRODUCT : VOKKERO GUARDIAN ATEX RANGE

Since 2017, the VOKKERO GUARDIAN ATEX range has been developed to facilitate communication between teams on SEVESO and ATEX classified sites, where the risks of major accidents require a high level of prevention.

The current crisis on the components market added to the many industrialization specificities of ATEX products lead today to important production difficulties inducing long periods of unavailability for our clients.

VOGO has been working for a long time in many industrial sectors and our roadmap has always been to provide the most professional quality of service possible. The manufacturing context for ATEX products does not allow us to do so anymore. The management of VOGO, together with its sales and marketing teams, are therefore decided to stop selling the VOKKERO GUARDIAN ATEX range with immediate effect.

Products affectedย :

–ย ย ย ย ย ย ย ย ย ย FULL DUPLEX WALKIE TALKIE ATEXย (Ref : VOKKER-GUARD-FCE001-EX / ARF8158AA)

–ย ย ย ย ย ย ย ย ย ย GUARDIAN ATEX 2 TO 4ย (Refย : VOK-GUARD-FCE02-03-04-EXNH)

–ย ย ย ย ย ย ย ย ย ย GUARDIAN ATEX 5 TO 8ย (Refย : VOK-GUARD-FCE05-06-07-08-EXN)

–ย ย ย ย ย ย ย ย ย ย ATEX HEADSET HIGH QUALITYย (Refย : PEL 490)

–ย ย ย ย ย ย ย ย ย ย BOOM-MIC HEADSET ATEX APPROVEDย (Refย : CLA 490)

–ย ย ย ย ย ย ย ย ย ย IN-EAR ATEX HEADSETย (Refย : SEN 490)

End of sale and availability:ย 10/10/2022

End of After Sales Service: 28/02/2023

Our teams are at your disposal for any further information: CONTACT Do not hesitate to contact your usual sales contact if necessary.

Share this article:

Other related articles

  • Researchers from CNRS, Sys2Diag laboratories get equipped withย VOKKERO GUARDIAN

    The collaboration of VOGO and Sys2Diag did not end with the EasyCov project. When researchers at the famous research laboratory learned about the functionality and performance of the VOKKERO GUARDIAN systems marketed by VOGO, they immediately understood how much help they could give them in many of their daily tasks. The example of the clinical study…